Pharmacist-led Continuous Glucose Monitoring
ConditionType 2 Diabetes
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of South Florida
About this trial
This is a pilot study. The goal of this prospective cohort study is to determine impact of pharmacist-led continuous glucose monitoring on glycemic control and health behavior change in people with type 2 diabetes. The main questions it aims to answer are:
1. to assess change in hemoglobin A1c in people with type 2 diabetes using continuous glucose monitoring under a pharmacist-led approach as compared to a pharmacist-led approach utilizing no continuous glucose monitoring (only self-monitoring blood glucose with a glucometer). 2. to assess change in continuous glucose monitoring-derived glycemic outcomes among the pharmacist-led continuous glucose monitoring cohort (intervention group) 3. to assess change in health behavior among the pharmacist-led continuous glucose monitoring cohort (intervention group)
Eligibility criteria
Qualifiers
type 2 diabetes
hemoglobin A1c ≥ 8%
compatible smartphone with FreeStyle Libre 2 or Libre 3+ continuous glucose monitoring system
current use and access to a glucometer for self-monitoring of blood glucose
Disqualifiers
any continuous glucose monitor use within 6 months prior to study enrollment
pregnant and planning to become pregnant during study time frame
history of hypoglycemia requiring third party assistance
history of diabetic ketoacidosis or hyperosmolar hyperglycemic state within 6 months prior to study enrollment
Trial design
Treatments tested in this trial
- FreeStyle Libre 2/Libre 3+ Continuous Glucose Monitor
Treatment groups
40 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov